mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.8 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |